Background: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). Objectives: To assess the significance of DH/BS in patients with IM. Methods: Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1. Results: 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05). Conclusion: In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study / Pijnenburg, Luc; Giannini, Margherita; Bouchard-Marmen, Maude; Arnaud, Laurent; Barsotti, Simone; Bellando-Randone, Silvia; Bernardi, Livio; Bini, Paola; Blagojevic, Jelena; Codullo, Veronica; Couderc, Marion; De Moreuil, Claire; Dernis, Emanuelle; Diamanti, Luca; Dubost, Jean Jacques; Duval, Fanny; Emmi, Giacomo; Galempoix, Jean-Marc; Geny, Bernard; Gottenberg, Jacques-Eric; Groza, Monica; Guffroy, Aurelien; Guichard, Isabelle; Guilpain, Philippe; Hervier, Baptiste; Hudson, Marie; Iaccarino, Luca; Iannone, Florenzo; Lebrun, Delphine; Marchioni, Enrico; Mariampillai, Kuberaka; Maurier, Francois; Mosca, Marta; Nadaj-Pakleza, Aleksandra; Nannini, Carlotta; Piot, Jean-Maxime; Prieto-González, Sergio; Poursac, Nicolas; Rouanet, Eglantine; Sellam, Jérémie; Selva-O'Callaghan, Albert; Séverac, François; Sibilia, Jean; Sole, Guilhem; Soulages, Antoine; Terrier, Benjamin; Tournadre, Anne; Troyanov, Yves; Vernier, Nathalie; Vesperini, Veronique; Viallard, Jean-François; Ziane, Rahima; Cavagna, Lorenzo; Meyer, Alain. - In: RMD OPEN. - ISSN 2056-5933. - ELETTRONICO. - 9:(2023), pp. e003081-e003081. [10.1136/rmdopen-2023-003081]
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study
Bellando-Randone, Silvia;Emmi, Giacomo;
2023
Abstract
Background: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). Objectives: To assess the significance of DH/BS in patients with IM. Methods: Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1. Results: 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05). Conclusion: In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).File | Dimensione | Formato | |
---|---|---|---|
e003081.full.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
1.51 MB
Formato
Adobe PDF
|
1.51 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.